Puls Biznesu: A biotech company, Biotts is preparing the ground for a revolution in the drug administration process. Although R&D works are still pending, the company claims that it has already found willing pharmaceutical concerns to handle what is known in the world of start-ups as the proof-of-concept.
The solutions that are currently available on the market allow for a transdermal administration of only small quantities of fat-soluble substances. Therefore, our method is a groundbreaking one. You will read more about our carrier and other patents in the article by Anna Bełcik.
